From: The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients
Factor | Log (Odds) | p | Odds ratio (95% CI) |
---|---|---|---|
Age (birth to 20 years/>60 years) | -0.0510 | 0.96 | |
Age (21 to 40 years/>60 years) | 1.7097 | 0.09 | |
Age (41 to 59 years/>60 years) | 0.7511 | 0.84 | |
Gender (male/female) | 1.2523 | 0.19 | |
Race (Caucasian/non-Caucasian) | -0.0818 | 0.92 | |
Diabetes mellitus (no/yes) | -0.6709 | 0.12 | |
System (standard/double bag) | 1.2585 | 0.22 | |
Treatment time on CAPD | |||
<1 year | 0.2074 | 0.89 | |
>1 year | 0.9547 | 0.21 | |
Treatment with vancomycin | |||
Oxacillin susceptible/oxacillin resistant | -0.1070 | 0.89 | |
No treatment with vancomycin | |||
Oxacillin susceptible/oxacillin resistant | 1.9440 | 0.01 | 137 (3.0; 6,202.4) |
Etiological agent | |||
S. epidermidis/S. aureus | 2.2548 | 0.02 | 9.5 (1.3; 69.6) |
Other CoNS/S. epidermidis | -1.6113 | 0.08 | |
Slime production (no/yes) | 4.2139 | 0.001 | 68 (5.0; 914.8) |